Collateral Damage: The Cardiovascular Cost of Suppressing COVID-19 Transmission in Australia

Saved in:
Bibliographic Details
Published inHeart, lung & circulation Vol. 29; no. 8; pp. 1109 - 1111
Main Authors Adikari, Dona H., Kushwaha, Virag V., Jepson, Nigel S.
Format Journal Article
LanguageEnglish
Published Australia Elsevier B.V 01.08.2020
Published by Elsevier B.V. on behalf of Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ)
Subjects
Australia - epidemiology
Betacoronavirus
Cardiovascular disease
Cardiovascular Diseases - diagnosis
Cardiovascular Diseases - epidemiology
Cardiovascular Diseases - therapy
Communicable Disease Control - organization & administration
Coronavirus Infections - epidemiology
Coronavirus Infections - prevention & control
Coronavirus Infections - transmission
COVID-19
Humans
Myocardial infarction
Pandemics - prevention & control
Pneumonia, Viral - epidemiology
Pneumonia, Viral - prevention & control
Pneumonia, Viral - transmission
SARS-CoV-2
Australia
Myocardial infarction
Cardiovascular disease
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Editorial-2
ObjectType-Commentary-1
ISSN:1443-9506
1444-2892
DOI:10.1016/j.hlc.2020.06.008